Filing Details
- Accession Number:
- 0001179110-17-002951
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-22 17:57:34
- Reporting Period:
- 2017-02-17
- Filing Date:
- 2017-02-22
- Accepted Time:
- 2017-02-22 17:57:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645118 | Jared Watkin | 100 Abbott Park Road Abbott Park IL 60064 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2017-02-17 | 7,393 | $0.00 | 53,955 | No | 4 | A | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-20 | 740 | $44.69 | 53,215 | No | 4 | F | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-21 | 683 | $44.69 | 52,532 | No | 4 | F | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-21 | 300 | $44.98 | 52,232 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-21 | 100 | $44.98 | 52,132 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-21 | 100 | $44.99 | 52,032 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-21 | 55 | $44.99 | 51,977 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Acquisiton | 2017-02-17 | 51,129 | $0.00 | 51,129 | $44.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
51,129 | 2018-02-17 | 2027-02-16 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Shares Without Par Value | 444 | Indirect | Profit Sharing Trust |
Footnotes
- These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- Balance in the Abbott Laboratories Stock Retirement Trust as of February 17, 2017.
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 17,043 on 02/17/2018, 17,043 on 02/17/2019, and 17,043 on 02/17/2020.